CLPB.F Stock Overview
Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Coloplast A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 123.01 |
| 52 Week High | DKK 143.15 |
| 52 Week Low | DKK 108.00 |
| Beta | 0.34 |
| 11 Month Change | -5.48% |
| 3 Month Change | -4.35% |
| 1 Year Change | 16.60% |
| 33 Year Change | -30.48% |
| 5 Year Change | 3.82% |
| Change since IPO | 14.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLPB.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -7.1% | -1.2% | -2.1% |
| 1Y | 16.6% | 22.4% | 29.6% |
Return vs Industry: CLPB.F underperformed the US Medical Equipment industry which returned 22.4% over the past year.
Return vs Market: CLPB.F underperformed the US Market which returned 29.6% over the past year.
Price Volatility
| CLPB.F volatility | |
|---|---|
| CLPB.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CLPB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CLPB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 16,639 | Kristian Villumsen | www.coloplast.com |
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
Coloplast A/S Fundamentals Summary
| CLPB.F fundamental statistics | |
|---|---|
| Market cap | US$28.28b |
| Earnings (TTM) | US$712.99m |
| Revenue (TTM) | US$3.81b |
39.7x
P/E Ratio7.4x
P/S RatioIs CLPB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLPB.F income statement (TTM) | |
|---|---|
| Revenue | DKK 27.03b |
| Cost of Revenue | DKK 8.76b |
| Gross Profit | DKK 18.27b |
| Other Expenses | DKK 13.22b |
| Earnings | DKK 5.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 04, 2025
| Earnings per share (EPS) | 22.44 |
| Gross Margin | 67.59% |
| Net Profit Margin | 18.69% |
| Debt/Equity Ratio | 120.6% |
How did CLPB.F perform over the long term?
See historical performance and comparison